Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (331-340 of 597) with videos related to

Pageof 60
Sort By:
British Journal of Haematology|March 26, 2013
CEBPA double-mutated acute myeloid leukaemia harbours concomitant molecular mutations in 76·8% of cases with TET2 and GATA2 alterations impacting prognosisVera Grossmann, Claudia Haferlach, Niroshan Nadarajah, et al.
Leukemia|October 9, 2025
Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutationsMaki Sakuma, Amy K Wang, Samuel J Magaziner, et al.
Leukemia|August 8, 2022
Alternatively spliced CSF3R isoforms in SRSF2 P95H mutated myeloid neoplasmsBorwyn A Wang, Hrishikesh M Mehta, Srinivasa R Penumutchu, et al.
European Journal of Haematology|October 30, 2013
Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasmsYuewen Fu, Thomas Schroeder, Tatjana Zabelina, et al.
Haematologica|May 9, 2024
A case of familial donor-derived acute myeloid leukemia with underlying pre-leukemic mutationsLuca Vincenzo Cappelli, Clara Minotti, Manja Meggendorfer, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Localized heme sensing through a ternary molecular glueMichael Heider, Clara Hipp, Zhi Yang, et al.
Leukemia Research|December 15, 2012
Evaluation of the proposed reporting system of the European LeukemiaNet and recommendations for prognosis of acute myeloid leukemiaTamara Alpermann, Wolfgang Kern, Susanne Schnittger, et al.
Leukemia|November 5, 2020
Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivoChristoph Rummelt, Sivahari P Gorantla, Manja Meggendorfer, et al.
Blood|June 19, 2002
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual diseaseSusanne Schnittger, Claudia Schoch, Martin Dugas, et al.
Haematologica|September 8, 2018
Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencingElisabeth K M Mack, André Marquardt, Danny Langer, et al.
Pageof 60

Showing results (331-340 of 597) with videos related to

Sort By:
Pageof 60
British Journal of Haematology|March 26, 2013
CEBPA double-mutated acute myeloid leukaemia harbours concomitant molecular mutations in 76·8% of cases with TET2 and GATA2 alterations impacting prognosisVera Grossmann, Claudia Haferlach, Niroshan Nadarajah, et al.
Leukemia|October 9, 2025
Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutationsMaki Sakuma, Amy K Wang, Samuel J Magaziner, et al.
Leukemia|August 8, 2022
Alternatively spliced CSF3R isoforms in SRSF2 P95H mutated myeloid neoplasmsBorwyn A Wang, Hrishikesh M Mehta, Srinivasa R Penumutchu, et al.
European Journal of Haematology|October 30, 2013
Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasmsYuewen Fu, Thomas Schroeder, Tatjana Zabelina, et al.
Haematologica|May 9, 2024
A case of familial donor-derived acute myeloid leukemia with underlying pre-leukemic mutationsLuca Vincenzo Cappelli, Clara Minotti, Manja Meggendorfer, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Localized heme sensing through a ternary molecular glueMichael Heider, Clara Hipp, Zhi Yang, et al.
Leukemia Research|December 15, 2012
Evaluation of the proposed reporting system of the European LeukemiaNet and recommendations for prognosis of acute myeloid leukemiaTamara Alpermann, Wolfgang Kern, Susanne Schnittger, et al.
Leukemia|November 5, 2020
Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivoChristoph Rummelt, Sivahari P Gorantla, Manja Meggendorfer, et al.
Blood|June 19, 2002
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual diseaseSusanne Schnittger, Claudia Schoch, Martin Dugas, et al.
Haematologica|September 8, 2018
Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencingElisabeth K M Mack, André Marquardt, Danny Langer, et al.
Pageof 60